NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT

FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory eff...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SONG DONG, LU TSJUN, MOREJDZHIS MAJKL EHNTONI, TSZIN' TSINVU, BLASKO ANDREJ, VONDERVELL BRENDA S'JU
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SONG DONG
LU TSJUN
MOREJDZHIS MAJKL EHNTONI
TSZIN' TSINVU
BLASKO ANDREJ
VONDERVELL BRENDA S'JU
description FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2319702C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2319702C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2319702C23</originalsourceid><addsrcrecordid>eNqNjMFKAzEURWfjQtR_eMsO9IGTaRGXMcmYQJIX3mRgokgpMq5EC_XD_QTT6ge4unA551w235GiLY9Mo6LkFCguY5beu2hgi8-rpxZXWxz8REwokGbCbi1QO1t0fXqLLmry2GPxTpto2mCyLf4FY7XF2FbpjM6lMoE4Wapx3FQ-MaUTKdabGvz1sLOYCvM5qSQ_0CxDDUOQ3shsYJQ-ryFZyUEqM2WnpAdFIdHosqMIMmo4tUjDQAxKRmUYMlc7mJivm4u3_ftxufnbqwYGk5XF5fC5W46H_evysXzteBJ9d393K5To_4H8APY-Wbw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><source>esp@cenet</source><creator>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</creator><creatorcontrib>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</creatorcontrib><description>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2319702C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2319702C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SONG DONG</creatorcontrib><creatorcontrib>LU TSJUN</creatorcontrib><creatorcontrib>MOREJDZHIS MAJKL EHNTONI</creatorcontrib><creatorcontrib>TSZIN' TSINVU</creatorcontrib><creatorcontrib>BLASKO ANDREJ</creatorcontrib><creatorcontrib>VONDERVELL BRENDA S'JU</creatorcontrib><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><description>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMFKAzEURWfjQtR_eMsO9IGTaRGXMcmYQJIX3mRgokgpMq5EC_XD_QTT6ge4unA551w235GiLY9Mo6LkFCguY5beu2hgi8-rpxZXWxz8REwokGbCbi1QO1t0fXqLLmry2GPxTpto2mCyLf4FY7XF2FbpjM6lMoE4Wapx3FQ-MaUTKdabGvz1sLOYCvM5qSQ_0CxDDUOQ3shsYJQ-ryFZyUEqM2WnpAdFIdHosqMIMmo4tUjDQAxKRmUYMlc7mJivm4u3_ftxufnbqwYGk5XF5fC5W46H_evysXzteBJ9d393K5To_4H8APY-Wbw</recordid><startdate>20080320</startdate><enddate>20080320</enddate><creator>SONG DONG</creator><creator>LU TSJUN</creator><creator>MOREJDZHIS MAJKL EHNTONI</creator><creator>TSZIN' TSINVU</creator><creator>BLASKO ANDREJ</creator><creator>VONDERVELL BRENDA S'JU</creator><scope>EVB</scope></search><sort><creationdate>20080320</creationdate><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><author>SONG DONG ; LU TSJUN ; MOREJDZHIS MAJKL EHNTONI ; TSZIN' TSINVU ; BLASKO ANDREJ ; VONDERVELL BRENDA S'JU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2319702C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SONG DONG</creatorcontrib><creatorcontrib>LU TSJUN</creatorcontrib><creatorcontrib>MOREJDZHIS MAJKL EHNTONI</creatorcontrib><creatorcontrib>TSZIN' TSINVU</creatorcontrib><creatorcontrib>BLASKO ANDREJ</creatorcontrib><creatorcontrib>VONDERVELL BRENDA S'JU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SONG DONG</au><au>LU TSJUN</au><au>MOREJDZHIS MAJKL EHNTONI</au><au>TSZIN' TSINVU</au><au>BLASKO ANDREJ</au><au>VONDERVELL BRENDA S'JU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT</title><date>2008-03-20</date><risdate>2008</risdate><abstract>FIELD: organic chemistry, medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to nonhygroscopic crystalline 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,2-dimethyl-1H-pyrrol-3-carboxamide maleate salt that possesses inhibitory effect on tyrosine kinase receptors. Also, invention relates to a pharmaceutical composition and to a method for treatment of cancer in mammals using such compositions. ^ EFFECT: valuable medicinal property of compound and pharmaceutical composition. ^ 12 cl, 12 tbl, 17 dwg, 5 ex</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2319702C2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A58%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SONG%20DONG&rft.date=2008-03-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2319702C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true